Managers / Q2 2025 · view latest →
Global Frontier Investments LLC
CIK 0001821219 · 92 BROAD STREET, CHARLESTON, SC, 29401 · 4154020285
Summary
Global Frontier Investments LLC reported $419M in U.S.-listed holdings across 23 positions for Q2 2025.
The portfolio is heavily concentrated: JPM alone accounts for 26.2% of reported value.
Compared with Q4 2024, the fund opened 8 new positions and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 98.6% · $414M
- ADR · 1.4% · $6M
- Other · 0.0% · $0
Quarter-over-Quarter Changes full breakdown →
vs Q4 2024 (amended baseline) · note: prior filed quarter, not the immediately preceding one
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| AMRYT PHARMA LTD - SPNR ADR | NEW | +0 | 0 | +$0 | $0 |
| OZKBANK OZK | NEW | +0 | 0 | +$0 | $0 |
| CCITIGROUP INC | NEW | +0 | 0 | +$0 | $0 |
| ATAI LIFESCIENCES NV | NEW | +0 | 0 | +$0 | $0 |
| CADENCE BANCORP | NEW | +0 | 0 | +$0 | $0 |
| WFCWELLS FARGO | NEW | +0 | 0 | +$0 | $0 |
| SCHWSCHWAB (CHARLES) CORP | NEW | +0 | 0 | +$0 | $0 |
| KALEYRA INC | NEW | +0 | 0 | +$0 | $0 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2025
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | JPMJPMORGAN CHASEhistory → | COMMON EQUITY | 26.20% | $110M | 379.0K |
| 2 | AXPAMERICAN EXPRESS COhistory → | COMMON EQUITY | 15.00% | $63M | 197.2K |
| 3 | PGRPROGRESSIVE CORPhistory → | COMMON EQUITY | 11.58% | $49M | 182.0K |
| 4 | MAMASTERCARD INC Ahistory → | COMMON EQUITY | 9.11% | $38M | 68.0K |
| 5 | BRK/ABERKSHIRE HATHAWAY INC CL Ahistory → | COMMON EQUITY | 7.65% | $32M | 44 |
| 6 | USBUS BANCORPhistory → | COMMON EQUITY | 6.02% | $25M | 558.0K |
| 7 | WALWESTERN ALLIANCE BANCORPhistory → | COMMON EQUITY | 5.30% | $22M | 285.0K |
| 8 | GSGOLDMAN SACHS GROUP INChistory → | COMMON EQUITY | 4.22% | $18M | 25.0K |
| 9 | AONAON PLC CLASS Ahistory → | COMMON EQUITY | 4.17% | $17M | 49.0K |
| 10 | ACGLARCH CAPITAL GROUP LTDhistory → | COMMON EQUITY | 3.26% | $14M | 150.0K |
| 11 | KKRKKRhistory → | COMMON EQUITY | 2.89% | $12M | 91.0K |
| 12 | BABAALIBABA GROUP HOLDING-SP ADRhistory → | COMMON EQUITY | 1.35% | $6M | 50.0K |
| 13 | GPNGLOBAL PAYMENTS INChistory → | COMMON EQUITY | 1.30% | $5M | 68.0K |
| 14 | ACNACCENTURE PLC CL Ahistory → | COMMON EQUITY | 1.07% | $4M | 15.0K |
| 15 | NTRSNORTHERN TRUST CORP | COMMON EQUITY | 0.91% | $4M | 30.0K |
| 16 | SCHWSCHWAB (CHARLES) CORP | COMMON EQUITY | 0.00% | $0 | 0 |
| 17 | AMRYT PHARMA LTD - SPNR ADR | COMMON EQUITY | 0.00% | $0 | 0 |
| 18 | CADENCE BANCORP | COMMON EQUITY | 0.00% | $0 | 0 |
| 19 | CCITIGROUP INC | COMMON EQUITY | 0.00% | $0 | 0 |
| 20 | OZKBANK OZK | COMMON EQUITY | 0.00% | $0 | 0 |
| 21 | KALEYRA INC | COMMON EQUITY | 0.00% | $0 | 0 |
| 22 | ATAI LIFESCIENCES NV | COMMON EQUITY | 0.00% | $0 | 0 |
| 23 | WFCWELLS FARGO | COMMON EQUITY | 0.00% | $0 | 0 |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026REVEALED | $1.2B | 53 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $507M | 23 | Feb 18, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $519M | 23 | Nov 18, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $419M | 23 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $389M | 23 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $335M | 23 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $341M | 23 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $231M | 23 | Dec 6, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $228M | 23 | Aug 16, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $223M | 23 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $227M | 23 | Feb 8, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $197M | 23 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $215M | 23 | Aug 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $259M | 23 | May 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $265M | 22 | Feb 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $137M | 19 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $132M | 18 | Aug 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $116M | 18 | May 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $103M | 18 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $68M | 17 | Nov 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $66M | 16 | Aug 17, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.